You Searched For "Zydus Lifesciences stock price" and got 20 results
Sort By:
Ajanta Pharma surges as much as 7% after the drug maker says it will buy back shares at 17% premium
Shares of Ajanta Pharma surged 7% today after the company announced a share buy back of 11.20 lakh …
Sensex, Nifty50 surge in morning trade led by banking and metal stocks
India’s benchmark indices Sensex and Nifty50 are likely to open in the green on Thursday amid posit…
Sensex, Nifty50 edge lower in morning trade, dragged by Infosys, Wipro and realty stocks
India’s equity markets are likely to open in the red on Wednesday amid negative cues in global mark…
Top stock movers — Future Retail, AstraZeneca, Cadila, DHFL, M&M, Indraprastha Gas, Gujarat Gas, Mahanagar Gas, and others
Indian equity benchmark indexes opened on a tepid note on Friday, tracking subdued cues from global…
Shares of UPL, India’s largest pesticide company, plunge by 13% after whistleblower alleges promoter fraud
The UPL share price plunged by over 13% on Thursday, December 10, after a whistleblower alleged tha…
IPOs in FY23 have been fewer but many have fared better than the previous year
The post-Covid boom saw 84 IPOs being listed on the stock exchanges in FY21 and FY22, but that pace…
Markets snap their six-day winning streak with a marginal fall
Indian stock markets came under pressure after a strong opening today amid reports on the Chinese m…
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
Markets trend higher as FII flows reverse and top companies hit 52-week high
In fact, the optimism is showing with foreign investors having bought ₹1,638 crore worth of equi…
US stocks retreat from record highs as stimulus deadlock continues
A deadlock in fiscal stimulus negotiations between Republicans and Democrats push stocks lower on W…
Matthew Fox
The utter chaos and confusion over Remdesivir in India is making the COVID-19 second wave worse
Remdesivir is not a proven treatment against COVID-19. Governments have said it, the courts hav…
India approves PLI scheme worth ₹10,900 crore in the food processing industry – FMCG stocks celebrate the news
“This will benefit farmers; this is a fitting tribute to 'Annadatas' (food providers), who despi…
Enough stock of hydroxychloroquine in India: Govt
India currently has an annual installed capacity of around 40 tonnes of active pharmaceutical ingr…
PTI
Top stocks to watch – RIL, Coal India, Lupin, DLF, NIIT, Reliance Capital, Cadila Health, Dish TV, Vedanta, and others
Indian stock markets could extend their gains on Monday after the Nifty crossed the 13,700 level on…
₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500— here’s why
Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…
Cadila's new drug for rheumatoid arthritis gets permission for clinical trials in India
Indian drug maker Cadila Healthcare— which also owns brands like Complan, Glucon D, and Nycil aft…
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices
Seven Indian drugmakers - Sun Pharma, Dr Reddy’s Laboratories, Glenmark Pharma, Lupin Wockhardt…
GOLDMAN SACHS: There's a strategy that will help you crush earnings season using these 20 stocks
The strategy goes as follows: if the closest listed at-the-money straddle for a stock is less expen…